COUP-TFIIはTGF-β誘発の成長障壁を阻害し,前立腺腫瘍形成を促進する
Jun Qin1, San-Pin Wu, Chad J Creighton
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Nature
|December 4, 2012
まとめ
COUP-TFIIは,PTEN変異性前立腺がんの自然な成長障壁を覆し,転移を促進します. COUP-TFIIを阻害することは,攻撃的な前立腺がんに対する新しい治療戦略を提供することができる.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- 前立腺がんには,しばしばPTEN変異やPI3K経路の変化が伴う.
- 鈍感なPTEN変異腫瘍が転移するメカニズムは不明である.
- 変形成長因子β (TGF-β) 信号は,PTEN主導の前立腺がん進行に対するチェックポイントとして機能する可能性があります.
研究 の 目的:
- PTEN変異性前立腺がんの進行におけるCOUP転写因子II (COUP-TFII) の役割を調査する.
- COUP-TFIIがTGF-βシグナル伝達と腫瘍転移に影響を与えるメカニズムを解明する.
主な方法:
- 特定の遺伝子削除 (PTEN,SMAD4) を含む遺伝子工学によるマウスモデルを使用した.
- SMAD4とのCOUP-TFIIの相互作用とそのTGF-β依存転写への影響を分析した.
- COUP-TFII発現が患者サンプルにおける臨床結果とTGF-βシグナル伝達と相関している.
主要な成果:
- COUP-TFIIはSMAD4依存の転写を阻害し,PTEN-null腫瘍におけるTGF-β成長障壁を覆す.
- COUP-TFII過剰発現はPTEN消去と連携し,マウスの攻撃的で転移性前立腺がんを誘導する.
- SMAD4の喪失は,COUP-TFIIアブレーションの抑制効果を相殺する.
- 高COUP-TFII発現は,腫瘍の再発および進行と相関し,患者におけるTGF-βシグナル伝達と逆相関する.
結論:
- COUP-TFIIは,TGF-β媒介の障壁を分解する重要な調節体であり,PTEN変異性前立腺がんの転移を可能にします.
- COUP-TFIIのターゲティングは,進行および転移性前立腺がんの治療のための潜在的な治療戦略を示しています.
関連する概念動画
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...


